US Dollar vs Yen

登録して無料でリアルタイムの株価、インタラクティブチャート、ライブオプションフローなどを入手してください。

ホーム
投資
株式
イギリス
LSE
APG SGA SA (0QN0) 銘柄情報

APG SGA SA (0QN0)

402.50

0.00

(0.00%)

終了 6月28日 12:30AM

APG SGA SA (0QN0) 銘柄情報

個人投資家向けのプロ仕様のツール。

プレミアム

通貨

402.50

( - )

買値

402.50

売値

402.50

出来高

681

0.00 日の範囲 0.00

402.50 52 週間の範囲 402.50

時価総額

前日終値

402.50

始値

-

時刻

最終取引時間

財務取引量

-

VWAP

-

平均取引量 (3 か月)

CHF 5,053

発行済株式数

2,997,757

配当利回り

12 (6.59%)

PER

20.82

1 株当たり利益 (EPS)

9.03

歳入

329.04M

純利益

27.08M

APG|SGA SA provides advertising services primarily in Switzerland and Serbia. The company offers its products in various formats, including F4, F12, F200, and F24 classic analog poster formats; bigposter; roofstrip bus and tram; eboard; epanel; windowsdecal; fullwrap bus, tram and locomotive; fullre... APG|SGA SA provides advertising services primarily in Switzerland and Serbia. The company offers its products in various formats, including F4, F12, F200, and F24 classic analog poster formats; bigposter; roofstrip bus and tram; eboard; epanel; windowsdecal; fullwrap bus, tram and locomotive; fullrearwrap; hangingdisplay; hangingdisplay with dispenser; megaposter; mobile targeting; mountain screen; pylonposter; railposter; railpostermidi; rearwindows and rearbody vinyl; time/informationboard; trafficboard; and trafficmediascreen. It also provides outdoor advertising on streets, squares, railway stations, shopping centers, the mountains, airports, and other points of interest, as well as digital and mobile advertising, such as ChannelOOH, programmatic adverting, Next level DOOH, and aymo mobile targeting solutions. In addition, the company involved in real estate services. The company was founded in 1900 and is headquartered in Geneva, Switzerland. 詳細を表示

セクター

-

業界

-

ウェブサイト

www.apgsga.ch

本社

Geneva, Switzerland

設立

2026

APG SGA SA is listed in the sector of the ロンドン証券取引所 with ticker 0QN0. The last closing price for APG SGA was CHF402.50. Over the last year, APG SGA shares have traded in a share price range of CHF 402.50 to CHF 402.50.

APG SGA currently has 2,997,757 shares in issue. The market capitalisation of APG SGA is CHF1.21 billion. APG SGA has a price to earnings ratio (PE ratio) of 20.82.

表示するニュースはありません。

期間 †	前日比	前日比 %	始値	高値	安値	平均出来高	VWAP
1	0	0	0	0	0	0	0	DE
4	0	0	0	0	0	0	0	DE
12	0	0	0	0	0	0	0	DE
26	0	0	402.5	402.5	402.5	474	402.5	DE
52	0	0	402.5	402.5	402.5	211	402.5	DE
156	0	0	402.5	402.5	402.5	79	402.5	DE
260	0	0	402.5	402.5	402.5	90	402.5	DE

0QN0 - Frequently Asked Questions (FAQ)

What is the current APG SGA SA share price?

The current share price of APG SGA SA is CHF 402.50

How many APG SGA SA shares are in issue?

APG SGA SA has 2,997,757 shares in issue

What is the market cap of APG SGA SA?

The market capitalisation of APG SGA SA is CHF 1.21B

What is the 1 year trading range for APG SGA SA share price?

APG SGA SA has traded in the range of CHF 402.50 to CHF 402.50 during the past year

What is the PE ratio of APG SGA SA?

The price to earnings ratio of APG SGA SA is 20.82

What is the cash to sales ratio of APG SGA SA?

The cash to sales ratio of APG SGA SA is 1.71

What is the registered address of APG SGA SA?

The registered address for APG SGA SA is Carrefour de Rive1, Geneva, Geneva, 1207

What is the APG SGA SA website address?

The website address for APG SGA SA is www.apgsga.ch

EnchantedPioneer31

EnchantedPioneer31 3分前

HOW TO FIND A LEGITIMATE CRYPTO RECOVERY WITH MIGHTY HACKER RECOVERY 2026

Hosai

It will need another larger trial yes. Out of interest though what do you think CHMPs report would have been had Donanemab applied to Europe based on their phase 2? LLY attempted to apply to FDA based on the phase 2 but were rejected, I imagine the CHMP report for an ap based on the phase 2 would ha

mm41

And by the way, this is my last comment and response to your lecturing. Do whatever you want, but I consume what I want and I give value to whichever analysis I choose. I am sick and tired of the suit-and-tie 'experts' who break their necks trying to tell us a stock will shoot to the moon when it’s

TrendTrade2016

TrendTrade2016 5分前

Maggots and Clowns getting smoked. All his scams are bleeding out. All his scams play the narrative….first alternative energy Fusion scam….then alternative jet fuel scam….then his copper scam …based on the copper industry narrative pump. Global copper shortage…omg how is AI going to happen without c

goodietime

goodietime 9分前

" 1 USD for my commons "
Any idea how many Commons are out there?

mm41

First of all, I am not the lady behind the Fortress Report—I am simply a subscriber who actually bothers to read deep-dive forensics instead of chasing FOMO charts.

Secondly, who cares where a high-quality analysis is posted? Good data is good data, whether it’s found on a penny stock

thesaud

thesaud 11分前

https://finance.yahoo.com/markets/stocks/articles/michael-burry-pulls-back-massive-020300513.html

Implanting

Implanting 12分前

I just read this article speaking to this 50-year gold-backed treasury bond. It may answer some of our questions about what it actually is and does.

This is Judy Shelton's version, so I'm guessing if they do it, there could be some tweaks to this version, but it would be close to this

EternalPatience

EternalPatience 21分前

Hole shot King

Hole shot King 22分前

Might be time to buy again ?

AI Overview

The maximum limit of Shiba Inu (SHIB) coins is fixed. The total supply can never go higher than 589.55 trillion coins. The system cannot make any more of them.

Key Details:Total Supply: The absolut

SC8

We already know that "study" wasn't what FDA asked for. And again, what happened to the second set of rabbits? What is MK hiding? You think FDA won't again see right through this nonsense?

vuletini

vuletini 24分前

What's your favorite pom pom color

sluggercjb

sluggercjb 25分前

DB you say that you talk to Rich frequently and have confidence in Dr. Otiko (Dr. Dirtbag) well ask a few very, very simple questions What did they sell who they sold it to how much $$$ they sold it for and more importantly where is the MONEY $$$$ .. it’s not that hard. Ya don’t have to be a Ro

12yearplan

12yearplan 31分前

But, just about 10 years of pain ombow and then we should be outta this brimstone (sulphur) and other issues
43:30 is a good summary as any, gl
https://www.youtube.com/watch?v=YlVPRutom6k

wannabeeriche

wannabeeriche 32分前

The Future

Over the next phase Bionano will move from selling a powerful lab tool to building the backbone of precision medicine by doing three practical things:

FIRST, make Saphyr the standard safety and diagnostic test that doctors and researchers use to spot big, har

SeaBlue

SeaBlue 36分前

What would be really good is if we get positive EA news from the govt AND Trumper revaluing gold. I think he'll revalue gold because of his ego. Just saw the proposed new US passport book pages - and Trump put a drawing of himself in the new passport design. C'mon, too much ego.

jimr1717

jimr1717 42分前

Smart move. Dumping Doug knew to sell this heap too.

bigstocksnbonds

bigstocksnbonds 42分前

Congrats on finishing the painting way to go!!!!! I know you’re happy!!!!

Sideem

Sideem 51分前

Either way, it's going up!!!!!

couldbebetter

couldbebetter 54分前

Jesspro, Otsuka already sells the drug in many countries,
if any company understands the potential it should be them.
Why they have not made a BO offer yet is beyond me. As time
goes by the patent clock continues to run and the potential value
of AUPH goes up as other d

theorysuit

theorysuit 54分前

Why do you need clearance to publish your own data. Companies do it all the time. The application was submitted 3 years ago. This app is already finished As in cooked.

valuemind

valuemind 57分前

Thanks, Wade, they have been all discussed on this board or picked at stock picking competitions. I feel uneasy to specifically list them all in one message and disclose publicly, because the top one has grown into over 50% of my total portfolio even after I sold 10%. It has been a 40 bagger, and my

Quantum Genomics

International bond 1.25%...

First Trust Consumer Sta...

FlexShares STOXX Global ...

Mercantile Bank

MainFirst Top European I...

Aclaris Therapeutics

Agf Us Sector Class Seri...

Delayed Upgrade Clock

顧客サポート: +44 (0) 203 8794 460 | support@advfn.com

ADVFNのサービスをご利用いただくには、利用規約

ADVFN

すでにアカウントをお持ちですか？サインイン

アカウントをお持ちでないですか？登録

登録することで、ADVFN の利用規約を読み、理解し、同意したこと、および私が個人投資家であることを確認します。